191 related articles for article (PubMed ID: 37381736)
21. Targeting NHE6 gene expression identifies lysosome and neurodevelopmental mechanisms in a haploid in vitro cell model.
Wu Q; Ma L; Joesch-Cohen L; Schmidt M; Uzun EDG; Morrow EM
Biol Open; 2023 Nov; 12(11):. PubMed ID: 37747131
[TBL] [Abstract][Full Text] [Related]
22. Loss of Christianson Syndrome Na
Pescosolido MF; Ouyang Q; Liu JS; Morrow EM
J Neurosci; 2021 Nov; 41(44):9235-9256. PubMed ID: 34526390
[TBL] [Abstract][Full Text] [Related]
23. Human iPSC lines from a Christianson syndrome patient with NHE6 W523X mutation, a biologically-related control, and CRISPR/Cas9 gene-corrected isogenic controls.
Ma L; Schmidt M; Morrow EM
Stem Cell Res; 2021 Jul; 54():102435. PubMed ID: 34182254
[TBL] [Abstract][Full Text] [Related]
24. Novel c.1505_1509dupCTGCC pathogenic variation in a male case with Christianson syndrome.
Yalcintepe S; Gurkan H
Clin Dysmorphol; 2021 Jan; 30(1):36-38. PubMed ID: 33278113
[TBL] [Abstract][Full Text] [Related]
25. Successful Treatment of Electrographic Status Epilepticus of Sleep With Felbamate in a Patient With SLC9A6 Mutation.
Coorg R; Weisenberg JL
Pediatr Neurol; 2015 Dec; 53(6):527-31. PubMed ID: 26421989
[TBL] [Abstract][Full Text] [Related]
26. The expanding phenotypic spectrum of female SLC9A6 mutation carriers: a case series and review of the literature.
Sinajon P; Verbaan D; So J
Hum Genet; 2016 Aug; 135(8):841-50. PubMed ID: 27142213
[TBL] [Abstract][Full Text] [Related]
27. X-linked Angelman-like syndrome caused by Slc9a6 knockout in mice exhibits evidence of endosomal-lysosomal dysfunction.
Strømme P; Dobrenis K; Sillitoe RV; Gulinello M; Ali NF; Davidson C; Micsenyi MC; Stephney G; Ellevog L; Klungland A; Walkley SU
Brain; 2011 Nov; 134(Pt 11):3369-83. PubMed ID: 21964919
[TBL] [Abstract][Full Text] [Related]
28. Functional Assessment
Ouyang Q; Joesch-Cohen L; Mishra S; Riaz HA; Schmidt M; Morrow EM
eNeuro; 2019; 6(6):. PubMed ID: 31676550
[TBL] [Abstract][Full Text] [Related]
29. Loss of endosomal exchanger NHE6 leads to pathological changes in tau in human neurons.
Fernandez MA; Bah F; Ma L; Lee Y; Schmidt M; Welch E; Morrow EM; Young-Pearse TL
Stem Cell Reports; 2022 Sep; 17(9):2111-2126. PubMed ID: 36055242
[TBL] [Abstract][Full Text] [Related]
30. Human neurons from Christianson syndrome iPSCs reveal mutation-specific responses to rescue strategies.
Lizarraga SB; Ma L; Maguire AM; van Dyck LI; Wu Q; Ouyang Q; Kavanaugh BC; Nagda D; Livi LL; Pescosolido MF; Schmidt M; Alabi S; Cowen MH; Brito-Vargas P; Hoffman-Kim D; Gamsiz Uzun ED; Schlessinger A; Jones RN; Morrow EM
Sci Transl Med; 2021 Feb; 13(580):. PubMed ID: 33568516
[TBL] [Abstract][Full Text] [Related]
31. Epilepsy in Christianson syndrome: Two cases of Lennox-Gastaut syndrome and a review of literature.
Ikeda A; Yamamoto A; Ichikawa K; Tsuyusaki Y; Tsuji M; Iai M; Enomoto Y; Murakami H; Kurosawa K; Miyatake S; Matsumoto N; Goto T
Epilepsy Behav Rep; 2020; 13():100349. PubMed ID: 31879735
[TBL] [Abstract][Full Text] [Related]
32. A loss-of-function mutation in the SLC9A6 gene causes X-linked mental retardation resembling Angelman syndrome.
Takahashi Y; Hosoki K; Matsushita M; Funatsuka M; Saito K; Kanazawa H; Goto Y; Saitoh S
Am J Med Genet B Neuropsychiatr Genet; 2011 Dec; 156B(7):799-807. PubMed ID: 21812100
[TBL] [Abstract][Full Text] [Related]
33. Electrical status epilepticus in sleep, a constitutive feature of Christianson syndrome?
Mathieu ML; de Bellescize J; Till M; Flurin V; Labalme A; Chatron N; Sanlaville D; Chemaly N; des Portes V; Ostrowsky K; Arzimanoglou A; Lesca G
Eur J Paediatr Neurol; 2018 Nov; 22(6):1124-1132. PubMed ID: 30126759
[TBL] [Abstract][Full Text] [Related]
34. Early lysosome defects precede neurodegeneration with amyloid-β and tau aggregation in NHE6-null rat brain.
Lee Y; Miller MR; Fernandez MA; Berg EL; Prada AM; Ouyang Q; Schmidt M; Silverman JL; Young-Pearse TL; Morrow EM
Brain; 2022 Sep; 145(9):3187-3202. PubMed ID: 34928329
[TBL] [Abstract][Full Text] [Related]
35. Inaugural Christianson Syndrome Association conference: families meeting for the first time.
Stein DM; Gerber A; Morrow EM
J Neurodev Disord; 2014; 6(1):13. PubMed ID: 25273398
[TBL] [Abstract][Full Text] [Related]
36. Christianson syndrome in a patient with an interstitial Xq26.3 deletion.
Tzschach A; Ullmann R; Ahmed A; Martin T; Weber G; Decker-Schwering O; Pauly F; Shamdeen MG; Reith W; Oehl-Jaschkowitz B
Am J Med Genet A; 2011 Nov; 155A(11):2771-4. PubMed ID: 21932316
[TBL] [Abstract][Full Text] [Related]
37. Christianson Syndrome across the Lifespan: An International Longitudinal Study in Children, Adolescents, and Adults.
Kavanaugh BC; Elacio J; Best CR; St Pierre DG; Pescosolido MF; Ouyang Q; Caruso P; Buch K; Biedermann J; Bradley RS; Liu JS; Jones RN; Morrow EM
medRxiv; 2023 Nov; ():. PubMed ID: 37987014
[TBL] [Abstract][Full Text] [Related]
38. Novel
Nan H; Kim YJ; Tsuchiya M; Ishida A; Haro H; Hiraide M; Ohtsuka T; Takiyama Y
Neurol Genet; 2022 Feb; 8(1):e651. PubMed ID: 35198730
[TBL] [Abstract][Full Text] [Related]
39. Slc9a6 mutation causes Purkinje cell loss and ataxia in the shaker rat.
Figueroa KP; Anderson CJ; Paul S; Dansithong W; Gandelman M; Scoles DR; Pulst SM
Hum Mol Genet; 2023 May; 32(10):1647-1659. PubMed ID: 36621975
[TBL] [Abstract][Full Text] [Related]
40. A novel splicing mutation in
Ieda D; Hori I; Nakamura Y; Ohashi K; Negishi Y; Hattori A; Arisaka A; Hasegawa S; Saitoh S
Hum Genome Var; 2019; 6():15. PubMed ID: 30937176
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
